Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Hosted on MSN6mon
Which 10 prescription drug prices are dropping in 2026 after negotiations? What we knowNovoLog FlexPen, NovoLog PenFill are all insulin or insulin infectors for patients with diabetes. Last year, they ran a list price of $495 for 30 days, the new price of $119 is 76% cheaper.
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
your insulin costs will be $35 a month, period," he said. The agreement reached with Novo Nordisk covers popular brands like Flasp, Novolin, NovoLog and Tresib, with three vials or two packs of ...
SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback